We also observed an increased trend in Bax and a decreased trend in Bcl2 protein expression following the combined NEK2 knockdown and IR treatment, as well as with NEK2 knockdown or IR treatment alone in both ESCC cell lines (Fig. 4C). The gene discussed is BAX; the disease is esophageal squamous cell carcinoma.